CV Sciences (CVSI) Capital Expenditures (2013 - 2026)
CV Sciences (CVSI) reported Capital Expenditures of $3000.0 for Q1 2026, down 92.5% on a YoY basis from $40000.0 in Q1 2025, and down 66.67% sequentially from $9000.0 in Q4 2025.
CV Sciences (CVSI) Capital Expenditures (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 12 years of Capital Expenditures data on file, last reported at $3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 92.5% year-over-year to $3000.0; the trailing twelve-month figure through Mar 2026 stood at $72000.0 (up 24.14% YoY), and the FY2025 full-year result was $109000.0, up 505.56% from the prior year.
- Capital Expenditures eased to $3000.0 in Q1 2026, from $9000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $49000.0 in Q2 2025 to a low of $3000.0 in Q1 2026.
- A 3-year average of $21666.7 and a median of $14500.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 50.0% in 2025 and plunged 92.5% in 2026, its largest moves.
- Tracing CVSI's Capital Expenditures over 3 years: stood at $18000.0 in 2024, then tumbled by 50.0% to $9000.0 in 2025, then tumbled by 66.67% to $3000.0 in 2026.
- Business Quant data shows CVSI's Capital Expenditures at $3000.0 in Q1 2026, $9000.0 in Q4 2025, and $11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Dec 31, 2020 | 818,000.00 |
| Dec 31, 2020 | 818,000.00 |
| Sep 30, 2020 | -267,000.00 |
| Sep 30, 2020 | -267,000.00 |
| Jun 30, 2020 | 430,000.00 |
| Jun 30, 2020 | 430,000.00 |